Collaboration: Engelhard Arzneimittel

Collaboration: Engelhard Arzneimittel

Emtex Life Science is very proud to have contributed to a review about the efficacy and safety of a product developed by Engelhard Arzneimittel GmbH & Co, KG.

 

The review provides an overview of clinical evidence concerning the efficacy and safety of the ivy leaf dry extract EA 575® in pediatric and adult patients with respiratory disease: https://www.thieme-connect.com/products/ejournals/html/10.1055/a-2745-1130.

 

Are you also ready for a fruitful collaboration with our medical writing team?

Find out more about our writing services, including manuscripts, graphical abstracts, responses to letters to the editor, and many more, here: https://www.emtexlifescience.com/services#media-communications.

 

Customer testimonial:

 

“Expert writers with a thorough understanding of regulatory documents and requirements.
Customer oriented, on time delivery of documents, high quality at a reasonable price.
Ability to take on complex projects and deliver with outstanding quality.”

Director Medical Writing